Marc Feldmann
Papers
1
Total Citations
36
H-Index
1
About
Marc Feldmann is a pioneering immunologist whose research has fundamentally reshaped our understanding and treatment of autoimmune diseases. His key contributions lie in cytokine biology and the pathogenesis of rheumatoid arthritis (RA). Feldmann’s landmark discovery, alongside Sir Ravinder Maini, was that tumor necrosis factor-alpha (TNF-α) acts as a master regulator in the inflammatory cascade of RA. By demonstrating that blocking TNF-α could suppress the production of other pro-inflammatory cytokines, he established a new therapeutic paradigm. This work directly led to the development of anti-TNF therapies (e.g., infliximab), which have transformed the lives of millions of patients with RA and other inflammatory conditions. While his most cited paper on antigen-specific suppressor factors (1979) laid early groundwork in immunology, his seminal studies on TNF blockade have garnered tens of thousands of citations, reflecting their immense clinical impact. For this breakthrough, Feldmann has received numerous accolades, including the Lasker Award and the Crafoord Prize, cementing his legacy as a translational scientist who bridged bench research to bedside therapy.
Research Focus
Key Achievements
Top Papers
- 1